Feds Take Pharma To Court

A drug company with a costly treatment for kidney patients is under federal investigation. The Competition Bureau alleges Otsuka Canada Pharmaceutical Inc. of Saint-Laurent, Que. acted to “prevent or delay generic versions of this product from coming to market”.

This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)

Back to Top